70842-225 : Kimyrsa 1200 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 70842-225 |
Labeler: | Melinta Therapeutics, LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Kimyrsa |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | NDA214155 |
Rev. Date: |
NDC Package Codes:
- 70842-225-01: 1 VIAL IN 1 CARTON (70842‑225‑01) > 40 ML IN 1 VIAL
Active Ingredients:
- Oritavancin Diphosphate
Dosage Strength:
- 1200 mg/40mL
Pharmaceutical Classes:
- Cytochrome P450 2C19 Inhibitors [MoA]
- Cytochrome P450 2C9 Inhibitors [MoA]
- Cytochrome P450 2D6 Inducers [MoA]
- Cytochrome P450 3A4 Inducers [MoA]
- Lipoglycopeptide Antibacterial [EPC]
- Lipoglycopeptides [EXT]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 70842-160Next: 70842-240 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.